SUSMED,Inc. (TYO:4263)
Japan flag Japan · Delayed Price · Currency is JPY
821.00
-34.00 (-3.98%)
Jul 25, 2025, 3:30 PM JST

SUSMED,Inc. Income Statement

Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
45334253031611534
Revenue Growth (YoY)
33.23%-35.47%67.72%174.78%238.24%-
Cost of Revenue
101281191
Gross Profit
44333052230510633
Selling, General & Admin
459452394309190107
Research & Development
26824317622624986
Operating Expenses
727695570535439193
Operating Income
-284-365-48-230-333-160
Other Non Operating Income (Expenses)
584126071
EBT Excluding Unusual Items
-279-357-44-218-273-89
Gain (Loss) on Sale of Assets
-----4-7
Asset Writedown
-4-2-5-15--
Other Unusual Items
-3----
Pretax Income
-283-356-49-233-277-96
Income Tax Expense
111---
Net Income
-284-357-50-233-277-96
Net Income to Common
-284-357-50-233-277-96
Shares Outstanding (Basic)
171716151312
Shares Outstanding (Diluted)
171716151312
Shares Change (YoY)
0.77%1.77%11.71%14.76%11.19%-
EPS (Basic)
-16.93-21.39-3.05-15.87-21.65-8.34
EPS (Diluted)
-16.93-21.39-3.05-15.87-21.65-8.34
Free Cash Flow
--23394-177--
Free Cash Flow Per Share
--13.965.73-12.05--
Gross Margin
97.79%96.49%98.49%96.52%92.17%97.06%
Operating Margin
-62.69%-106.73%-9.06%-72.78%-289.56%-470.59%
Profit Margin
-62.69%-104.39%-9.43%-73.73%-240.87%-282.35%
Free Cash Flow Margin
--68.13%17.74%-56.01%--
EBITDA
-279-360-43-228--
EBITDA Margin
-61.59%-105.26%-8.11%-72.15%--
D&A For EBITDA
5552--
EBIT
-284-365-48-230-333-160
EBIT Margin
-62.69%-106.73%-9.06%-72.78%-289.56%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.